Clinical trial
Empagliflozin Functional Capacity - Non-Interventional Study
NCT05350202 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Empagliflozin Functional Capacity - Non-Interventional Study
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 18, 2022
- Completion date
- July 25, 2024
- Enrollment
- 3,431 (actual)
- Sites
- 350
Conditions
As the registry lists them; a condition with its own page is linked.